>>Description of the research protocol "Pepita"

Preoperative Chemosensitivity Testing as Predictor of Treatment Benefit in Adjuvant Stage III Colon Cancer: PePiTA Trial
Phase II study| Status : Ongoing (but closed to recruitment)

Additional details

Indication (or studied pathology) : Gastro-onco
Brugmann identifier : Pepita
EudraCT identifier : 2009-011445-13
ClinicalTrials.gov identifier : NCT00994864


Involved department : Hemato-oncology
Principal investigator : Efira
Sponsor : IJB
Contact : Clinical Research Unit

>This protocol was approved by the Bordet ethics committee.